homoarginine has been researched along with Chronic Illness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carru, C; Mangoni, AA; McEvoy, M; Rodionov, RN; Sotgia, S; Zinellu, A | 1 |
Kienreich, K; März, W; Meinitzer, A; Pieber, TR; Pilz, S; Putz-Bankuti, C; Stauber, RE; Stojakovic, T | 1 |
Branson, LF; Connor, JR; Currie, MG; Dorn, CR; Hallinan, EA; Hansen, DW; Jerome, GM; Manning, PT; Moore, WM; Pitzele, BS; Tsymbalov, S; Widomski, DL; Zhang, Y | 1 |
1 review(s) available for homoarginine and Chronic Illness
Article | Year |
---|---|
New horizons in arginine metabolism, ageing and chronic disease states.
Topics: Aged; Aging; Arginine; Chronic Disease; Homoarginine; Humans | 2019 |
2 other study(ies) available for homoarginine and Chronic Illness
Article | Year |
---|---|
Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
Topics: Adult; Aged; Arginine; Chronic Disease; Disease-Free Survival; Female; Follow-Up Studies; Homoarginine; Humans; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Survival Rate | 2015 |
Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.
Topics: Acute Disease; Administration, Oral; Animals; Arthritis, Experimental; Carrageenan; Chronic Disease; Crystallization; Edema; Enzyme Inhibitors; Homoarginine; Humans; Isoenzymes; Lysine; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prodrugs; Rats; Recombinant Proteins | 2002 |